{"subsection_name": "Research", "pub_date": "2011-10-25T00:00:00Z", "byline": {"original": "By ANAHAD O'CONNOR", "contributor": "", "person": [{"lastname": "O'CONNOR", "organization": "", "rank": 1, "role": "reported", "firstname": "Anahad"}]}, "abstract": "Analysis in journal The Lancet Oncology finds breast cancer drug letrozole reduces the chances that a woman's cancer will return and improves her odds of survival to a greater degree than tamoxifen, a widely used estrogen blocker.", "word_count": "212", "print_page": "6", "news_desk": "Science", "snippet": "The drug letrozole reduces the chances that a woman\u2019s breast cancer will return and improves her odds of survival to a greater degree than tamoxifen, a study shows.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "subject", "is_major": "Y", "value": "Breast Cancer", "rank": "1"}, {"name": "subject", "is_major": "N", "value": "Women and Girls", "rank": "2"}, {"name": "subject", "is_major": "N", "value": "Medicine and Health", "rank": "3"}, {"name": "subject", "is_major": "N", "value": "Tamoxifen (Drug)", "rank": "5"}, {"name": "subject", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "rank": "6"}], "type_of_material": "News", "lead_paragraph": "The drug letrozole reduces the chances that a woman\u2019s breast cancer will return and improves her odds of survival to a greater degree than tamoxifen, a study shows.", "web_url": "http://www.nytimes.com/2011/10/25/health/research/25regimens.html", "section_name": "Health", "headline": {"main": "Regimens: Better Blocker of Breast Cancer Recurrence", "print_headline": "Regimens: Better Blocker of Breast Cancer Recurrence", "kicker": "Vital Signs", "seo": "Letrozole Surpasses Tamoxifen at Reducing Breast Cancer Recurrence", "content_kicker": "Vital Signs"}, "slideshow_credits": null, "_id": "5176da28cf28d02a610028be", "document_type": "article"}